Solution Structure and Interaction with Basic and Acidic Fibroblast Growth Factor of a 3-kDa Human Platelet Factor-4 Fragment with Antiangiogenic Activity* 210
暂无分享,去创建一个
M. Redondo-Horcajo | A. Bikfalvi | P. Cuevas | R. Lozano | G. Giménez-Gallego | M. Jiménez | M. Rico | Mariano Redondo-Horcajo | Manuel Rico | L. Zilberberg | Rosa M. Lozano | M.Ángeles Jiménez | Lior Zilberberg | Pedro Cuevas | Andréas Bikfalvi | Guillermo Giménez-Gallego
[1] M. Redondo-Horcajo,et al. A short peptide domain of platelet factor 4 blocks angiogenic key events induced by FGF‐2 , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[2] B D Sykes,et al. Chemical shifts as a tool for structure determination. , 1994, Methods in enzymology.
[3] W. Stafford,et al. Physical characterization of myosin light chains. , 1978, Biochemistry.
[4] V. Saudek,et al. Gradient-tailored excitation for single-quantum NMR spectroscopy of aqueous solutions , 1992, Journal of biomolecular NMR.
[5] S. Mandriota,et al. Vascular endothelial growth factor-induced in vitro angiogenesis and plasminogen activator expression are dependent on endogenous basic fibroblast growth factor. , 1997, Journal of cell science.
[6] T. F. Kumosinski,et al. Measurements of protein hydration by various techniques. , 1985, Methods in enzymology.
[7] G. Giménez-Gallego,et al. Human brain-derived acidic and basic fibroblast growth factors: amino terminal sequences and specific mitogenic activities. , 1986, Biochemical and biophysical research communications.
[8] A. Pineda-Lucena,et al. 1H-NMR assignment and solution structure of human acidic fibroblast growth factor activated by inositol hexasulfate. , 1994, Journal of Molecular Biology.
[9] J. Thornton,et al. A revised set of potentials for β‐turn formation in proteins , 1994 .
[10] G. Giménez-Gallego,et al. Conversion of cysteine to serine residues alters the activity, stability, and heparin dependence of acidic fibroblast growth factor. , 1991, The Journal of biological chemistry.
[11] M. Redondo-Horcajo,et al. 1H NMR structural characterization of a nonmitogenic, vasodilatory, ischemia-protector and neuromodulatory acidic fibroblast growth factor. , 2000, Biochemistry.
[12] D. W. Bolen,et al. Unfolding free energy changes determined by the linear extrapolation method. 1. Unfolding of phenylmethanesulfonyl alpha-chymotrypsin using different denaturants. , 1988, Biochemistry.
[13] K. Wüthrich. NMR of proteins and nucleic acids , 1988 .
[14] R. R. Ernst,et al. Two‐dimensional spectroscopy. Application to nuclear magnetic resonance , 1976 .
[15] H. Karasuyama,et al. Establishment of mouse cell lines which constitutively secrete large quantities of interleukin 2, 3, 4 or 5, using modified cDNA expression vectors , 1988, European journal of immunology.
[16] C. Tanford,et al. Molecular characterization of proteins in detergent solutions. , 1974, Biochemistry.
[17] C. Pace. Determination and analysis of urea and guanidine hydrochloride denaturation curves. , 1986, Methods in enzymology.
[18] L Serrano,et al. Helix stop and start signals in peptides and proteins. The capping box does not necessarily prevent helix elongation. , 1994, Journal of molecular biology.
[19] G. Gray,et al. Inhibition of angiogenesis by recombinant human platelet factor-4 and related peptides. , 1990, Science.
[20] G. Bodenhausen,et al. Natural abundance nitrogen-15 NMR by enhanced heteronuclear spectroscopy , 1980 .
[21] P. Wen,et al. Viral vector-mediated transduction of a modified platelet factor 4 cDNA inhibits angiogenesis and tumor growth , 1997, Nature Medicine.
[22] P. Cuevas,et al. Fibroblast growth factors, proteins with a broad spectrum of biological activities. , 1994, Neurological research.
[23] D. Rees,et al. Three-dimensional structures of acidic and basic fibroblast growth factors. , 1993, Science.
[24] Arthur J. Rowe,et al. Analytical ultracentrifugation in biochemistry and polymer science , 1992 .
[25] R. Lozano,et al. Solution structure of acidic fibroblast growth factor bound to 1,3, 6-naphthalenetrisulfonate: a minimal model for the anti-tumoral action of suramins and suradistas. , 1998, Journal of molecular biology.
[26] G. Gray,et al. Inhibition of tumor growth in mice by an analogue of platelet factor 4 that lacks affinity for heparin and retains potent angiostatic activity. , 1991, Cancer research.
[27] D. Mosher,et al. Platelet factor 4 modulates the mitogenic activity of basic fibroblast growth factor. , 1994, The Journal of clinical investigation.
[28] François Coulier,et al. Of Worms and Men: An Evolutionary Perspective on the Fibroblast Growth Factor (FGF) and FGF Receptor Families , 1997, Journal of Molecular Evolution.
[29] M. Jaye,et al. Fibroblast growth factor receptor tyrosine kinases: molecular analysis and signal transduction. , 1992, Biochimica et biophysica acta.
[30] P K Tsai,et al. Physical stabilization of acidic fibroblast growth factor by polyanions. , 1993, Archives of biochemistry and biophysics.
[31] N. Itoh,et al. Structure and expression of a novel human FGF, FGF-19, expressed in the fetal brain. , 1999, Biochimica et biophysica acta.
[32] M. Blaber,et al. Thermodynamic characterization of mutants of human fibroblast growth factor 1 with an increased physiological half-life. , 2000, Biochemistry.
[33] K Wüthrich,et al. A two-dimensional nuclear Overhauser enhancement (2D NOE) experiment for the elucidation of complete proton-proton cross-relaxation networks in biological macromolecules. , 1980, Biochemical and biophysical research communications.
[34] J. Singh,et al. Inhibition of endothelial cell proliferation by platelet factor-4 involves a unique action on S phase progression , 1994, The Journal of cell biology.
[35] P. Cuevas,et al. Protection of rat myocardium by mitogenic and non-mitogenic fibroblast growth factor during post-ischemic reperfusion. , 1997, Growth factors.
[36] L Serrano,et al. The folding of an enzyme. IV. Structure of an intermediate in the refolding of barnase analysed by a protein engineering procedure. , 1992, Journal of molecular biology.
[37] Y. Nemerson,et al. Human factor VIIa and its complex with soluble tissue factor: evaluation of asymmetry and conformational dynamics by ultracentrifugation and fluorescence anisotropy decay methods. , 1993, Biochemistry.
[38] K. Wüthrich,et al. Application of phase sensitive two-dimensional correlated spectroscopy (COSY) for measurements of 1H-1H spin-spin coupling constants in proteins. , 1983, Biochemical and biophysical research communications.
[39] A. Pineda-Lucena,et al. Effect of low pH and heparin on the structure of acidic fibroblast growth factor. , 1994, European journal of biochemistry.
[40] N. Ferrara. Molecular and biological properties of vascular endothelial growth factor , 1999, Journal of Molecular Medicine.
[41] H. Byers,et al. Growth inhibition of murine melanoma and human colon carcinoma by recombinant human platelet factor 4. , 1990, Journal of the National Cancer Institute.
[42] László Szilágyi,et al. Chemical shifts in proteins come of age , 1995 .
[43] Ad Bax,et al. MLEV-17-based two-dimensional homonuclear magnetization transfer spectroscopy , 1985 .
[44] Y H Chen,et al. Determination of the secondary structures of proteins by circular dichroism and optical rotatory dispersion. , 1972, Biochemistry.
[45] K. Wüthrich,et al. Torsion angle dynamics for NMR structure calculation with the new program DYANA. , 1997, Journal of molecular biology.
[46] C. MacArthur,et al. Receptor Specificity of the Fibroblast Growth Factor Family* , 1996, The Journal of Biological Chemistry.
[47] K Wüthrich,et al. Efficient computation of three-dimensional protein structures in solution from nuclear magnetic resonance data using the program DIANA and the supporting programs CALIBA, HABAS and GLOMSA. , 1991, Journal of molecular biology.
[48] A. Bikfalvi,et al. Platelet factor 4 modulates fibroblast growth factor 2 (FGF-2) activity and inhibits FGF-2 dimerization. , 1998, Blood.
[49] T. Laue,et al. Modern Analytical Ultracentrifugation , 1994, Emerging Biochemical and Biophysical Techniques.
[50] D. Rees,et al. Production and characterization of an analog of acidic fibroblast growth factor with enhanced stability and biological activity. , 1993, Protein engineering.
[51] R. Heinrikson,et al. Amino acid sequence of human platelet factor 4. , 1977, Proceedings of the National Academy of Sciences of the United States of America.
[52] A. Pineda-Lucena,et al. Three-dimensional structure of acidic fibroblast growth factor in solution: effects of binding to a heparin functional analog. , 1996, Journal of molecular biology.
[53] K Wüthrich,et al. The program XEASY for computer-supported NMR spectral analysis of biological macromolecules , 1995, Journal of biomolecular NMR.
[54] A. Bikfalvi,et al. Inhibition of in vitro angiogenesis by platelet factor-4-derived peptides and mechanism of action. , 1999, Blood.
[55] J. Fiddes,et al. Human basic fibroblast growth factor: nucleotide sequence and genomic organization. , 1986, The EMBO journal.
[56] G. Giménez-Gallego,et al. The complete amino acid sequence of human brain-derived acidic fibroblast growth factor. , 1986, Biochemical and biophysical research communications.
[57] J. Loscalzo,et al. The interaction of platelet factor four and glycosaminoglycans. , 1985, Archives of biochemistry and biophysics.
[58] Eric Oldfield,et al. 1H, 13C and 15N chemical shift referencing in biomolecular NMR , 1995, Journal of biomolecular NMR.
[59] David F. Burke,et al. Crystal structure of fibroblast growth factor receptor ectodomain bound to ligand and heparin , 2000, Nature.
[60] A. Halfpenny,et al. The structure of human acidic fibroblast growth factor and its interaction with heparin. , 1991, Archives of biochemistry and biophysics.
[61] A. Pineda-Lucena,et al. X-ray structure of native full-length human fibroblast-growth factor at 0.25-nm resolution. , 1996, European journal of biochemistry.
[62] Luis Serrano,et al. The hydrophobic-staple motif and a role for loop-residues in α-helix stability and protein folding , 1995, Nature Structural Biology.
[63] L. Chen,et al. Crystal structure of recombinant human platelet factor 4. , 1994, Biochemistry.
[64] L Serrano,et al. Development of the multiple sequence approximation within the AGADIR model of alpha-helix formation: comparison with Zimm-Bragg and Lifson-Roig formalisms. , 1997, Biopolymers.
[65] P E Wright,et al. Use of chemical shifts and coupling constants in nuclear magnetic resonance structural studies on peptides and proteins. , 1994, Methods in enzymology.
[66] J. Singh,et al. A potent inhibitor of endothelial cell proliferation is generated by proteolytic cleavage of the chemokine platelet factor 4. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[67] R. Hodges,et al. Effect of trifluoroethanol on protein secondary structure: an NMR and CD study using a synthetic actin peptide. , 1992, Biochemistry.
[68] T. Maione,et al. Inhibition of development of murine melanoma lung metastases by systemic administration of recombinant platelet factor 4. , 1995, Journal of the National Cancer Institute.
[69] Jeffrey D. Esko,et al. Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor , 1991, Cell.
[70] D. Moscatelli,et al. High and low affinity binding sites for basic fibroblast growth factor on cultured cells: Absence of a role for low affinity binding in the stimulation of plasminogen activator production by bovine capillary endothelial cells , 1987, Journal of cellular physiology.
[71] K Wüthrich,et al. Polypeptide secondary structure determination by nuclear magnetic resonance observation of short proton-proton distances. , 1984, Journal of molecular biology.
[72] J. Philo. An improved function for fitting sedimentation velocity data for low-molecular-weight solutes. , 1997, Biophysical journal.
[73] F. Blanco,et al. NMR evidence of a short linear peptide that folds into a .beta.-hairpin in aqueous solution , 1993 .
[74] P. Gleizes,et al. Cell Release of Bioactive Fibroblast Growth Factor 2 by Exon 6-encoded Sequence of Vascular Endothelial Growth Factor* , 1997, The Journal of Biological Chemistry.
[75] K. J. Brown,et al. Histidine-rich glycoprotein and platelet factor 4 mask heparan sulfate proteoglycans recognized by acidic and basic fibroblast growth factor. , 1994, Biochemistry.
[76] R. Bradshaw. TIBS—the second decade , 1986 .
[77] L. Kay,et al. Overcoming the overlap problem in the assignment of 1H NMR spectra of larger proteins by use of three-dimensional heteronuclear 1H-15N Hartmann-Hahn-multiple quantum coherence and nuclear Overhauser-multiple quantum coherence spectroscopy: application to interleukin 1 beta. , 1989, Biochemistry.
[78] G. D'alessio,et al. A method for synthesizing genes and cDNAs by the polymerase chain reaction. , 1993, Analytical biochemistry.
[79] M. Blaber,et al. X-ray crystal structure of human acidic fibroblast growth factor. , 1996, Biochemistry.
[80] R. Lozano,et al. High-level synthesis in Escherichia coli of shortened and full-length human acidic fibroblast growth factor and purification in a form stable in aqueous solutions. , 1992, Gene.